Suicide Crisis Syndrome: A review of supporting evidence for a new suicide-specific diagnosis.


Journal

Behavioral sciences & the law
ISSN: 1099-0798
Titre abrégé: Behav Sci Law
Pays: United States
ID NLM: 8404861

Informations de publication

Date de publication:
May 2019
Historique:
received: 26 10 2018
revised: 21 12 2018
accepted: 22 12 2018
pubmed: 23 3 2019
medline: 19 11 2019
entrez: 23 3 2019
Statut: ppublish

Résumé

Suicide is a major public health problem, and suicide rates are still on the rise. Current strategies for identifying individuals at risk for suicide, such as the use of a patient's self-reported suicidal ideation or evidence of past suicide attempts, have not been sufficient in reducing suicide rates. Recently, research groups have been focused on determining the acute mental state preceding a suicide attempt. The development of an acute suicidal diagnosis, the Suicide Crisis Syndrome (SCS), is aimed at capturing this state to better treat individuals. The SCS has five main evidence-based components-entrapment, affective disturbance, loss of cognitive control, hyperarousal, and social withdrawal. The SCS may provide clinicians with the ability to identify individuals who are experiencing an acute pre-suicidal mental state, regardless of their self-reported suicidal ideation. Future research leading to the incorporation of this diagnosis into clinical practice could improve the quality of care and reduce the personal, societal, and legal burden of suicide.

Identifiants

pubmed: 30900347
doi: 10.1002/bsl.2397
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-239

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Allison Schuck (A)

Department of Psychiatry, Mount Sinai Beth Israel, New York, NY, USA.

Raffaella Calati (R)

Department of Psychiatry, Mount Sinai Beth Israel, New York, NY, USA.

Shira Barzilay (S)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Sarah Bloch-Elkouby (S)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Igor Galynker (I)

Department of Psychiatry, Mount Sinai Beth Israel, New York, NY, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH